The firm said that its shares will begin trading on the OTCQB exchange starting on Feb. 22.
The firm was able to maintain a minimum closing bid price of at least $1 per share for at least 10 consecutive business days.
In December, the company effected a 1-for-10 reverse stock split in order to help regain compliance with Nasdaq's minimum closing bid requirement.
The firm recently enacted a 1-for-5 reverse stock split to help its shares meet the minimum bid price requirement for listing on the market.
As of Nov. 21 the company evidenced a closing bid price of its common stock in excess of the $1 minimum requirement for at least 10 consecutive trading days.
The molecular testing firm, which received a notice of potential delisting in January, said it may regain compliance through a reverse stock split, if necessary.
The molecular diagnostics company has been given 60 days to demonstrate that it's in compliance with TSX listing requirements.
The firm, which was previously listed on the over-the-counter market, anticipates $8.5 million in net proceeds from the offering.
The Australian firm regained compliance on a rule for a minimum $1 bid on its shares, while its deadline to meet a rule for a minimum $2.5 million in shareholders' equity was extended.
NEW YORK (GenomeWeb News) – NeoGenomics has been approved to list its shares on the Nasdaq Capital Market, the Ft. Myers, Fla.-based firm said today.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.